Ultra Market Research | United Kingdom Bioinformatics Market
United Kingdom Bioinformatics Market
Report ID : 958
Category : United-Kingdom(UK)
No Of Pages : 110
Published on: January 2025
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
UK Bioinformatics Market
Introduction
UK Bioinformatics market is rapidly emerging in the life sciences and healthcare industry driven by the fast demand for data-driven solutions within genomics, proteomics, and drug discovery. Bioinformatics brings together biology, computer science, and information technology to understand complex biological data. Recent trends of this market involve the adoption of artificial intelligence and machine learning into its products to further develop predictive models and speed up the research. As valued at about USD 1.2 billion in 2024, the bioinformatics sector of the UK is growing gradually as a result of increasing investment in genomic research, personalized medicine, and innovations in biotechnology. The present situation emphasizes a sound ecosystem with leading companies, research houses, and the government helping them to achieve newer heights.
Segmentation
Tools
Bioinformatics Platforms
Genomic Platforms
Next-Generation Sequencing Analysis
Microarray Analysis
Others
Proteomic Platforms
Protein Structure Prediction
Protein Interaction Analysis
Others
Software
Data Management Tools
Laboratory Information Management Systems (LIMS)
Clinical Data Management Tools
Data Analysis Software
AI-Based Analytics
Statistical Analysis Tools
Others
Services
Data Analysis Services
Genomic Data Analysis
DNA Sequencing Analysis
RNA Sequencing Analysis
Proteomic Data Analysis
Protein Quantification
Functional Analysis
Consulting Services
Research Consulting
IT Integration Consulting
Custom Services
Workflow Design
Bespoke Algorithm Development
Others
Applications
Genomics
Whole Genome Sequencing
Epigenomics
Others
Proteomics
Protein Identification
Structural Proteomics
Drug Discovery and Development
Target Identification
Biomarker Discovery
Precision Medicine
Personalized Treatment Plans
Diagnostic Tool Development
Others
Agricultural Biotechnology
Environmental Monitoring
List of Market Players
Illumina, Inc. (USA)
Thermo Fisher Scientific, Inc. (USA)
Qiagen N.V. (Germany)
Agilent Technologies, Inc. (USA)
Bio-Rad Laboratories, Inc. (USA)
PerkinElmer, Inc. (USA)
Waters Corporation (USA)
Oxford Nanopore Technologies (UK)
Roche Diagnostics (Switzerland)
DNASTAR, Inc. (USA)
Partek Incorporated (USA)
Eagle Genomics Ltd. (UK)
GSK (UK)
Biomatters Ltd. (New Zealand)
Seven Bridges Genomics (USA)
Drivers
Major factors that drive the UK bioinformatics market include advancements in genomic research and personalized medicine. Significant government backing is provided in terms of its Genomics England initiative and funds put into enhancing NHS genomic projects. The recent progress in the deployment of next-generation sequencing (NGS) technologies have made high-volume data production fast and less expensive, therefore propelling higher demands for more efficient bioinformatics tools and services. Increased incidence of chronic diseases and rare genetic conditions also expedite the development of precision medicine, which further propels the growth of the market. Innovative solutions for software and analytical tools from academia-industry partnerships are expanding the bioinformatics ecosystem, and the evolving trends of AI and ML are helping to streamline the interpretation and decision-making related to data.
Restraints
Despite its growth potential, the UK bioinformatics market has several challenges. High costs associated with advanced bioinformatics tools and platforms are a significant barrier, especially for SMEs. Data privacy and security concerns, especially in healthcare applications, are critical hurdles to widespread adoption. The lack of standardized protocols for data integration and analysis further complicates the process, limiting efficiency and scalability. The lack of skilled bioinformaticians in the UK workforce also impacts the timely completion of projects and the proper use of bioinformatics solutions. Regulatory barriers and complicated compliance requirements also hinder market development, especially for new entrants.
Opportunities
This opens a large, promising market for UK bioinformatics as AI and ML become increasingly adopted technologies. These can facilitate more rapid data processing and pattern recognition for predictive analysis. The expansion in partnerships between academies, biotech companies, and technology developers offers the opportunities for revolutionary discoveries and product design. Government-funded initiatives, including the UK BioBank and several genomics research programs, form an ideal incubator for further bioinformatics activities. Second, bioinformatics brings opportunities for agricultural biotechnology in market expansions as well as new avenues in environmental monitoring. Scaling big data and cloud computing solutions can also manage and analyze large datasets in biology.
Trend
The last recent trend within the UK bioinformatics market includes the emergence of cloud-based solutions. These types of solutions bring forth scalability and cost-effectiveness as well as enable real-time collaboration, where access to analysis is possible for the researcher irrespective of the place they are accessing from. Use of blockchain for improved data integrity and security - addressing privacy in genomic data sharing. In single-cell analysis, developments in multi-omics integration are going to contribute toward more intensive insights into biological systems. The company is also working on more user-friendly interfaces and features of automation to make bioinformatics tools accessible to a wider audience.
5. UK Bioinformatics Market by Patient Demographics
5.1 Introduction 5.2 Market Size and Growth Rate by Patient Demographics (2024-2030) 5.2.1 Children 5.2.1.1 Infants 5.2.1.2 Toddlers and Young Children 5.2.2 Adults 5.2.2.1 Young Adults 5.2.2.2 Seniors
6. UK Bioinformatics Market by Distribution Channels
6.1 Introduction 6.2 Market Size and Growth Rate by Distribution Channels (2024-2030) 6.2.1 Hospital Pharmacies 6.2.1.1 Tertiary Care Centers 6.2.1.2 Pediatric Oncology Units 6.2.2 Retail Pharmacies 6.2.2.1 Local Pharmacies 6.2.2.2 Chain Pharmacies 6.2.3 Online Pharmacies
7. UK Bioinformatics Market by Therapeutic Applications
Figure 10: Overview of Experimental Treatments in Bioinformatics
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done, and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of United Kingdom market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of United Kingdom Bioinformatics Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of United Kingdom Bioinformatics Market for the past year and forecasts for the next six years. United Kingdom Bioinformatics Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different United Kingdom Bioinformatics Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for United Kingdom Bioinformatics Market from different application industries in different regions.
